![Virtual Concert for NET Research](https://netrf.org/wp-content/uploads/2020/04/TiffannyandJosh-300x300.jpg)
Virtual Concert for NET Research
Tiffanny and Josh Thomson hosted “Music to Ignite NET Research,” a virtual fundraiser for NETRF in honor of Dr. Aaron Vinik.
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
Tiffanny and Josh Thomson hosted “Music to Ignite NET Research,” a virtual fundraiser for NETRF in honor of Dr. Aaron Vinik.
A group gathers for an overdrive exercise class to raise money in memory of an inspirational business leader, eGlobalTech founder and CEO Sonya Jain.
NETRF reports progress in the development of neuroendocrine tumor cell lines to help eliminate a decades-old obstacle in laboratory research. To stimulate progress in NET cell lines, NETRF established a Cell Line Prize, funded cell line research, and launched a collaboration with a nationally known research institute. Each of these initiatives has succeeded in establishing NET cell lines.
NETRF welcomes five new members to its Board of Scientific Advisors, a volunteer council of highly distinguished medical and research leaders who share NETRF’s commitment to advancing the diagnosis and treatment of neuroendocrine cancer.
In March of 2005, the Caring for Carcinoid Foundation was recognized as a non-profit, 501(c)3 foundation, established by a visionary group led by patient Nancy
Thank you for supporting NET research in 2019 Together we can fund research needed to find a cure for neuroendocrine cancer The 2019 results are
Research to Advance Neuroendocrine Tumor Treatment The Neuroendocrine Tumor Research Foundation (NETRF) today announced $3.5 million in neuroendocrine tumor (NET) research grants to fund 12
A NETRF-funded clinical trial looks at a cancer vaccine called SurVaxM in neuroendocrine cancer to help slow or stop the spread of neuroendocrine tumors.
After chemotherapy for pancreatic NET, Chef Jack Riebel embraces life with new optimism, doing what he enjoys most, and finding meaning by giving back.
Many people with neuroendocrine cancer look more deeply for meaning in their lives. They want to understand their purpose in life or why they got cancer.